Biogen and Amicus win UK Prix Galien awards for rare disease medicines
Biotechnology companies Biogen and Amicus have won the two top prizes for their rare disease medicines at the UK Prix…
Biotechnology companies Biogen and Amicus have won the two top prizes for their rare disease medicines at the UK Prix…
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for Lynparza (olaparib) to be used for the…
Rival companies have lined up create biosimilars for Humira (adalimumab), which is currently marketed by US-based biopharmaceutical company AbbVie, as…
The US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee has recommended approval of Celltrion's Rituxan biosimilar CT-P10. CT-P10…
The UK Government has made medical cannabis legal for the first time in the country for the treatment of patients…
Johnson & Johnson’s Janssen Pharmaceutical Companies has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for…
The Association of the British Pharmaceutical Industry (ABPI) has entered into a new partnership with the Academic Health Science Network…
US-based biotechnology companies Bluebird Bio and Gritstone Oncology have entered into strategic collaboration for the development of new cancer cell…
The European Medicines Agency (EMA) has accepted to review Mylan's marketing authorisation applications (MAA) for proposed biosimilar trastuzumab and proposed…
Japanese firm Astellas Pharma has exercised its exclusive option right to acquire US-based biotechnology company Mitobridge to accelerate the discovery…